The State Key Laboratory of Pharmaceutical Biotechnology.
The Department of Pharmacology and Pharmacy, The University of Hong Kong, Hong Kong SAR, China.
J Cardiovasc Pharmacol. 2021 Dec 1;78(Suppl 6):S63-S77. doi: 10.1097/FJC.0000000000001154.
SIRT1, a member of the sirtuin family of longevity regulators, possesses potent activities preventing vascular aging. The expression and function of SIRT1 in endothelial cells are downregulated with age, in turn causing early vascular aging and predisposing various vascular abnormalities. Overexpression of SIRT1 in the vascular endothelium prevents aging-associated endothelial dysfunction and senescence, thus the development of hypertension and atherosclerosis. Numerous efforts have been directed to increase SIRT1 signaling as a potential strategy for different aging-associated diseases. However, the complex mechanisms underlying the regulation of SIRT1 have posed a significant challenge toward the design of specific and effective therapeutics. This review aimed to provide a summary on the regulation and function of SIRT1 in the vascular endothelium and to discuss the different approaches targeting this molecule for the prevention and treatment of age-related cardiovascular and cerebrovascular diseases.
SIRT1 是长寿调控蛋白 Sirtuin 家族的成员,具有预防血管老化的强大活性。SIRT1 的表达和功能随着年龄的增长而下降,进而导致早期血管老化和各种血管异常。在血管内皮细胞中超表达 SIRT1 可预防与衰老相关的内皮功能障碍和衰老,从而预防高血压和动脉粥样硬化的发生。人们已经做出了许多努力来增加 SIRT1 信号,作为治疗不同与衰老相关疾病的一种潜在策略。然而,SIRT1 调节的复杂机制给针对该分子的特异性和有效治疗方法的设计带来了重大挑战。本综述旨在概述 SIRT1 在血管内皮中的调节和功能,并讨论针对该分子的不同方法,以预防和治疗与年龄相关的心血管和脑血管疾病。